Already recognized as one of the leaders in weight management, KitoZyme continues to focus on microbiota and digestive health with a new product to treat constipation. This is based on an exclusive and patented prebiotic technology.
TransiBiota is a class IIa medical device which is intended for use in:
- The treatment of moderate constipation
- The promotion of normal transit
- The relief of gastro-intestinal symptoms related to constipation and/or gut dysbiosis
- The cases of patients who are suffering from irritable bowel disease (IBS) in order to alleviate the IBS symptoms.
63% experienced an improvement of constipation symptoms after taking TransiBiota.
KiOslim is a class IIb medical device which provides the most complete action for losing weight. However, the weight management is not deserted so far since the success of KiOslim led KitoZyme to propose a new galenic form in order to improve the compliance and recruit new consumers with a film-coated tablet version of KiOslim.
- Reduces availability of carbohydrates for absorption
- Lowers fat intake from diet
- Reduces appetite for preventing excessive eating and cravings
KiOslim is 40% more efficient than a diet alone
KitoZyme is also proud to present its truly new end-consumer brand YAW – You Are Wonderful. A range of natural products for well-being: www.yaw.fr